Number of Ontarians taking stimulants more than doubled after pandemic, study finds
The number of adults in Ontario who started taking stimulants, mainly to treat ADHD, more than doubled in the wake of the COVID-19 pandemic, according to a new study that found women were the most frequent new consumers of medications once taken mostly by hyperactive boys.
The research, published Monday in the Canadian Medical Association Journal, showed that more than 220,000 adults in Ontario filled a new prescription for a stimulant such as Vyvanse or Concerta in the four years after March, 2020, up from about 107,000 in the four years beforehand.
